Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference30 articles.
1. Competing designs for phase I clinical trials: a review;WF Rosenberger;Stat Med,2002
2. Ting N (2006) Dose Finding in Drug Development. (New York: Springer.
3. Dose Escalation Methods in Phase I Cancer Clinical Trials;C Le Tourneau;Journal of the National Cancer Institute,2009
4. Review: new biological insights in early clinical studies;M Maur;Hematological Oncology,2007
5. Continual reassessment method: A practical design for phase I clinical trials in cancer;J O'Quigley;Biometrics,1990
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dose optimization for cancer treatments with considerations for late-onset toxicities;Clinical Trials;2024-04-09
2. A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma;Frontiers in Oncology;2023-06-09
3. A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations;Clinical Cancer Research;2022-05-12
4. A Brief Overview of Adaptive Designs for Phase I Cancer Trials;Cancers;2022-03-18
5. A nonparametric Bayesian method for dose finding in drug combinations cancer trials;Statistics in Medicine;2022-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3